MimetikOss is manufactured by mimicking natural processes of mineralization that take place in healthy bone. The physiological conditions to which it is subjected during its manufacture provide it with a microstructure, nanostructure and a porosity similar to those of the mineral phase of the bone, which sets it apart from others synthetic. Biomimicry allows to solve clinical problems such as lack of synchronization between degradation of the biomaterial and the neoformation of the bone. For this reason, MimetikOss is a unique bone graft in the market, which has been conceived to solve current clinical challenges and achieve a high reliability in surgery. MimetikOss is rapidly incorporated into the bone and is progressively remodeled until a stable and total regeneration of the bone defect is achieved, ensuring the clinical success of the treatment. M1METIKOSS Bone Graft Granules Size MIM-S MimetikOss S 0,2-1mm 1 ce MIM-M MimetikOss M 1-2mm 1 ce Why is MimetikOss revolutionary ? )j] Biomimicry: The only biomimetic graft in the market, similar in shape, structure and composition to the mineral phase of human bone: • 80% biomimetic calcium deficient hydroxiapatite • 2 0% biomimetic β-tricalcium phosphate Stable in volume: The graft is replaced progressively by new bone without loss of volume Indications: MimetikOss can be used to regenerate bone in multiple indications: • Spinal column: vertebral fusion, filling of intersomatic boxes Easy to use: Its hydrophilicity and porosity allow easy hydration and placement of the granules Safe: Manufactured in Spain under strict standards quality. Being synthetic, there is no risk of transmission of diseases. • Iliac crest harvesting • Upper limbs: humeral head fracture, glenoid prosthesis,humerus fracture, distal radius fracture • Lower limbs: femoral head fracture, femoral nail revision,screw extraction, hip prosthesis, knee prosthesis, tumoral filling, tibial fracture • Foot: calcaneal fracture, phalangeal fusion, talus fusion Presentation Product Ref. MimetikOss The first biomimetic bone graft susbtitute in the market CONTACT